HRT HRT Legal, Ethical & Documentation Standards 1 — Questions and Answers
Question 1: Which federal agency oversees compounding pharmacies that produce HRT preparations and issued guidance distinguishing traditional vs. outsourcing facility compounding?
- U.S. Food and Drug Administration (FDA) (Correct answer)
- Drug Enforcement Administration (DEA)
- Centers for Medicare & Medicaid Services (CMS)
- Health Resources & Services Administration (HRSA)
Correct answer: U.S. Food and Drug Administration (FDA)
The FDA regulates compounding pharmacies under the Drug Quality and Security Act (DQSA), distinguishing 503A (traditional) from 503B (outsourcing facility) compounders.
Question 2: Informed consent for HRT must include which core elements to be legally valid?
- Explanation of risks, benefits, alternatives, and confirmation that the patient understands and agrees voluntarily (Correct answer)
- Physician signature only
- Patient's insurance ID number
- Pharmacist's approval
Correct answer: Explanation of risks, benefits, alternatives, and confirmation that the patient understands and agrees voluntarily
Legally valid informed consent requires disclosing risks, benefits, and alternatives; confirming patient comprehension; and documenting the patient's voluntary agreement without coercion.
Question 3: HIPAA regulations require HRT practitioners to protect patient hormone therapy records in which fundamental way?
- Limit disclosure of protected health information (PHI) to the minimum necessary for treatment, payment, or operations (Correct answer)
- Share all records with any requesting provider
- Store all records only on paper
- Destroy records after 1 year
Correct answer: Limit disclosure of protected health information (PHI) to the minimum necessary for treatment, payment, or operations
HIPAA's minimum necessary standard requires that only the PHI needed for a specific purpose be accessed, shared, or disclosed, protecting patient privacy.
Question 4: When prescribing compounded HRT, a practitioner's documentation should include which element to satisfy medical necessity requirements?
- Documentation of why an FDA-approved product is inadequate for the patient's specific clinical need (Correct answer)
- A note stating the patient preferred compounded products
- Pharmacy's convenience as the reason
- Price comparison to FDA products
Correct answer: Documentation of why an FDA-approved product is inadequate for the patient's specific clinical need
Prescribing compounded HRT requires documenting clinical justification for why commercially available FDA-approved products cannot meet the patient's individualized need.
Question 5: Which professional body publishes the most authoritative clinical practice guidelines for menopause management in the United States?
- The Menopause Society (formerly NAMS — North American Menopause Society) (Correct answer)
- American Heart Association
- CDC
- NIH Office of Dietary Supplements
Correct answer: The Menopause Society (formerly NAMS — North American Menopause Society)
The Menopause Society (formerly NAMS) is the leading North American professional organization that publishes evidence-based HRT and menopause management guidelines.
Question 6: Testosterone is a Schedule III controlled substance in the United States. What does this classify it as?
- A drug with accepted medical use but moderate potential for dependence and abuse (Correct answer)
- An over-the-counter supplement
- A Schedule II narcotic
- An unregulated herbal product
Correct answer: A drug with accepted medical use but moderate potential for dependence and abuse
Schedule III substances have accepted medical use with moderate-to-low potential for physical or psychological dependence, and testosterone was added due to anabolic steroid abuse concerns.
HRT HRT Legal, Ethical & Documentation Standards 1
Which federal agency oversees compounding pharmacies that produce HRT preparations and issued guidance distinguishing traditional vs. outsourcing facility compounding?